Interferon Gamma-Inducible NAMPT in Melanoma Cells Serves as a Mechanism of Resistance to Enhance Tumor Growth
Cancers · 23.02.2023 · 15 (5) · 1411
DOI: 10.3390/cancers15051411 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 23.02.2023. Verfasst von Cindy Barba und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIA NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
(1)
Background
Immune cells infiltrate the tumor microenvironment and secrete inflammatory cytokines, including interferons (IFNs), to drive antitumor responses and promote tumor clearance. However, recent evidence suggests that sometimes, tumor cells can also harness IFNs to enhance growth and survival. The essential NAD+ salvage pathway enzyme nicotinamide phosphoribosyltransferase (NAMPT) gene is constitutively expressed in cells during normal homeostasis. However, melanoma cells have higher energetic demands and elevated NAMPT expression. We hypothesized that interferon gamma (IFNγ) regulates NAMPT in tumor cells as a mechanism of resistance that impedes the normal anti-tumorigenic effects of IFNγ. (2)
Methods
Utilizing a variety of melanoma cells, mouse models, Crispr-Cas9, and molecular biology techniques, we explored the importance of IFNγ-inducible NAMPT during melanoma growth. (3)
Results
We demonstrated that IFNγ mediates the metabolic reprogramming of melanoma cells by inducing Nampt through a Stat1 binding site in the Nampt gene, increasing cell proliferation and survival. Further, IFN/STAT1-inducible Nampt promotes melanoma in vivo. (4)
Conclusions
We provided evidence that melanoma cells directly respond to IFNγ by increasing NAMPT levels, improving their fitness and growth in vivo (control n = 36, SBS KO n = 46). This discovery unveils a possible therapeutic target that may improve the efficacy of immunotherapies involving IFN responses in the clinic.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA.
- Izmir Institute of Technology, Molecular Biology and Genetics Department, Gulbahce, Izmir 35430, Turkey.
ORCID-Profile: H Atakan Ekiz
Förderung
- NCI NIH HHS
- NIA NIH HHS
- NIAID NIH HHS
- National Institutes of Health Grants
- Huntsman Cancer Institute Melanoma Center Research Award
Zitieren
APA
Barba, C., Ekiz, H. A., Tang, W. W., Ghazaryan, A., Hansen, M., Lee, S. H., Voth, W. P., & O'Connell, R. M. (2023). Interferon Gamma-Inducible NAMPT in Melanoma Cells Serves as a Mechanism of Resistance to Enhance Tumor Growth. Cancers, 15(5), 1411. https://doi.org/10.3390/cancers15051411
Vancouver
Barba C, Ekiz HA, Tang WW, Ghazaryan A, Hansen M, Lee SH, et al. Interferon Gamma-Inducible NAMPT in Melanoma Cells Serves as a Mechanism of Resistance to Enhance Tumor Growth. Cancers. 2023;15(5):1411. doi:10.3390/cancers15051411
BibTeX
@article{Barba2023,
author = {Barba, Cindy and Ekiz, H Atakan and Tang, William Weihao and Ghazaryan, Arevik and Hansen, Mason and Lee, Soh-Hyun and Voth, Warren Peter and O'Connell, Ryan Michael},
title = {Interferon Gamma-Inducible NAMPT in Melanoma Cells Serves as a Mechanism of Resistance to Enhance Tumor Growth},
journal = {Cancers},
year = {2023},
volume = {15},
number = {5},
pages = {1411},
doi = {10.3390/cancers15051411}
}
EUVIMED